2022 - Research.com Medicine in Israel Leader Award
His primary areas of study are Internal medicine, Transplantation, Immunology, Surgery and Gastroenterology. Internal medicine and Oncology are commonly linked in his work. His research investigates the link between Oncology and topics such as Lymphoma that cross with problems in Chimeric antigen receptor and Minimal residual disease.
His Transplantation research is multidisciplinary, incorporating elements of Hematology and Transplantation Conditioning. His study in Immunology is interdisciplinary in nature, drawing from both Stem cell and Cell biology. His study looks at the intersection of Gastroenterology and topics like Immunotherapy with Adoptive cell transfer.
The scientist’s investigation covers issues in Internal medicine, Transplantation, Oncology, Immunology and Surgery. His Gastroenterology research extends to the thematically linked field of Internal medicine. The Transplantation study combines topics in areas such as Regimen, Stem cell, Cumulative incidence and Fludarabine.
His Oncology research includes themes of Retrospective cohort study, Chemotherapy and Multiple myeloma. His studies deal with areas such as Haematopoiesis and Cancer research as well as Immunology. His Hematopoietic stem cell transplantation study incorporates themes from Survival rate and Transplantation Conditioning.
Arnon Nagler mostly deals with Internal medicine, Transplantation, Oncology, Acute leukemia and Hematopoietic stem cell transplantation. The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways. His Transplantation research focuses on Incidence and how it connects with Multivariate analysis.
His research integrates issues of Refractory, Fludarabine, Multiple myeloma and Busulfan in his study of Oncology. His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Survival rate, Human leukocyte antigen and Univariate analysis. His Graft-versus-host disease research incorporates themes from Anti-thymocyte globulin and Immunology.
Arnon Nagler focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Acute leukemia. His Internal medicine study frequently intersects with other fields, such as Gastroenterology. His work carried out in the field of Transplantation brings together such families of science as Hematology, Retrospective cohort study, Total body irradiation, Stem cell and Disease.
His biological study spans a wide range of topics, including Young adult, Regimen, Marrow transplantation, Cell therapy and Fludarabine. Arnon Nagler interconnects Survival rate, Transplantation Conditioning, Cumulative incidence and Intensive care medicine in the investigation of issues within Hematopoietic stem cell transplantation. As a part of the same scientific study, Arnon Nagler usually deals with the Acute leukemia, concentrating on Busulfan and frequently concerns with ThioTEPA.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
Shimon Slavin;Arnon Nagler;Ella Naparstek;Yossi Kapelushnik.
The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.
Amnon Peled;Orit Kollet;Tanya Ponomaryov;Isabelle Petit.
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Robert Z. Orlowski;Arnon Nagler;Pieter Sonneveld;Joan Bladé.
Journal of Clinical Oncology (2007)
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Camille Abboud;Ellin Berman;Adam Cohen.
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni.
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Philippe Armand;Arnon Nagler;Edie A. Weller;Steven M. Devine.
Journal of Clinical Oncology (2013)
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party
Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser.
Journal of Clinical Oncology (2007)
Rapid and efficient homing of human CD34+CD38−/lowCXCR4+stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull mice
Orit Kollet;Asaf Spiegel;Amnon Peled;Isabelle Petit.
CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
Sigal Tavor;Isabelle Petit;Svetlana Porozov;Abraham Avigdor;Abraham Avigdor.
Cancer Research (2004)
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Nicolaus Kröger;Ernst Holler;Guido Kobbe;Martin Bornhäuser.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: